Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
239
pubmed:dateCreated
2004-1-27
pubmed:abstractText
Various studies suggest that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are promising anticancer agents. Epidemiological studies have found that long-term use of NSAIDs is associated with a reduced incidence of colorectal, gastric and oesophageal cancers, while experimental and clinical studies have demonstrated that treatment with NSAIDs causes a statistically significant reduction in both the number and the size of polyps in familial adenomatous polyposis (FAP) patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/PTGS1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases
pubmed:status
MEDLINE
pubmed:issn
0085-5928
pubmed:author
pubmed:issnType
Print
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
87-93
pubmed:dateRevised
2008-2-13
pubmed:meshHeading
pubmed-meshheading:14743889-Adenocarcinoma, pubmed-meshheading:14743889-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:14743889-Antineoplastic Agents, pubmed-meshheading:14743889-Barrett Esophagus, pubmed-meshheading:14743889-Cell Transformation, Neoplastic, pubmed-meshheading:14743889-Combined Modality Therapy, pubmed-meshheading:14743889-Cyclooxygenase 1, pubmed-meshheading:14743889-Cyclooxygenase 2, pubmed-meshheading:14743889-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:14743889-Cyclooxygenase Inhibitors, pubmed-meshheading:14743889-Esophageal Neoplasms, pubmed-meshheading:14743889-Humans, pubmed-meshheading:14743889-Isoenzymes, pubmed-meshheading:14743889-Membrane Proteins, pubmed-meshheading:14743889-Prognosis, pubmed-meshheading:14743889-Prostaglandin-Endoperoxide Synthases, pubmed-meshheading:14743889-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
pubmed:affiliation
Dept. of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. C.J.Buskens@AMC.UVA.NL
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Review, Research Support, Non-U.S. Gov't